Alamar Biosciences, Inc. · NASDAQ:ALMR
Yuling Luo reported 6 trades in Alamar Biosciences, Inc. shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 20, 2026
On Apr 20, 2026, Yuling Luo (Director, Chief Executive Officer) reported 6 trades in Alamar Biosciences, Inc. shares, leaving 0 shares. Filed Apr 20, 2026 (Form 4).
- Shares
- 3,088,217 shares
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Class B Common Stock | Conversion | 1,386,746 | 1,499,797 | Direct | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 364,268 | 1,864,065 | Direct | |
| Apr 20, 2026 | Common Stock | Other | 1,864,065 | 1,864,065 | Direct | |
| Apr 20, 2026 | Common Stock | Award | 76,509 | 1,940,574 | Direct | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 1,224,152 | 1,224,152 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Other | 1,224,152 | 0 | Indirect |